To include your compound in the COVID-19 Resource Center, submit it here.

S: Phase II/III suspended enrollment

Merck and Intercell suspended enrollment in a double-blind, placebo-controlled, international Phase II/III trial of V710 pending further analyses

Read the full 189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE